Browse Category

NYSE:KVUE News 14 October 2025 - 17 October 2025

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Stock Hits a 52-Week Low on Legal Woes Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge stocktwits.com. The one-day drop – Kenvue’s

17 October 2025

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Recent Market Moves Kenvue’s stock (NYSE: KVUE) has been volatile. On Oct 16, 2025 it closed around $15.46, marking a fresh 52-week low investing.com. Over the prior week the shares had slid

16 October 2025

Health Industry · Investment News · Market Analysis · NYSE:KVUE · Pharmaceutical Companies · Stock Market

J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

Background: J&J’s Three-Way Split Strategy Johnson & Johnson, a healthcare conglomerate, historically consisted of consumer health, pharmaceutical (Innovative Medicine), and medical technology divisions. In 2023 J&J spun off its consumer products (Tylenol,

14 October 2025

Business News · Corporate Strategy · Healthcare · Industry Trends · Medical Devices · NYSE:JNJ · NYSE:KVUE

Go toTop